https://www.educationaldoseillustrator.com/pp1m/schizophrenia/scenario/switching-from-oral-risperdal2018-10-18T11:32:32-04:000.5https://www.educationaldoseillustrator.com/privacy-policy2023-08-24T12:08:25-04:000.5https://www.educationaldoseillustrator.com/4042023-08-24T12:08:25-04:000.5https://www.educationaldoseillustrator.com/legal-notice2023-08-24T12:08:26-04:000.5https://www.educationaldoseillustrator.com/2023-08-24T12:08:25-04:000.75https://www.educationaldoseillustrator.com/pp3m/schizophrenia/scenario/switching-a-patient-to-invega-trinza-from-any-other-long-acting-injectable-lai-antipsychotic2018-04-17T11:26:24-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/scenario/switch-from-risperdal-consta-to-invega-sustenna-to-invega-trinza2018-04-16T16:17:52-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/scenario/switching-to-oral-invega-er-after-4th-invega-trinza-injection2018-04-16T23:33:07-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/scenario/switching-to-oral-invega-er-after-1st-invega-trinza-injection2018-04-16T23:29:57-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/scenario/after-4th-dose-of-invega-trinza2017-05-02T12:22:43-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/scenario/5th-injection-37-weeks-since-first-injection2018-04-16T23:25:45-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/scenario/after-1st-dose-of-invega-trinza2018-04-16T23:27:14-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/scenario/single-dose-curve-view2018-04-16T23:34:00-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/scenario/3rd-injection-37-weeks-since-2nd-injection2018-04-16T23:21:39-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/scenario/4th-injection-37-weeks-since-2nd-injection2018-04-16T23:22:31-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/scenario/2nd-injection-37-weeks-since-1st-injection2018-04-16T23:20:34-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/scenario/5th-injection-4-to-9-months-late2021-05-12T17:06:24-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/scenario/3rd-injection-4-to-9-months-late2021-05-12T17:06:16-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/scenario/4th-injection-4-to-9-months-late2021-05-12T17:06:08-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/scenario/2nd-injection-4-to-9-months-late2021-05-12T16:54:12-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/scenario/4th-injection-15-weeks-since-last-invega-trinza-injection2017-05-02T12:22:40-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/scenario/5th-injection-15-weeks-since-last-invega-trinza-injection2018-04-17T11:23:54-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/scenario/2nd-injection-15-weeks-since-last-invega-trinza-injection2017-05-02T12:22:39-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/scenario/3rd-injection-15-weeks-since-last-invega-trinza-injection2017-05-02T12:22:40-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/scenario/4th-injection-of-invega-trinza2017-05-02T12:22:39-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/scenario/5th-injection-of-invega-trinza2017-05-02T12:22:39-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/scenario/3rd-injection-of-invega-trinza2017-05-02T12:22:39-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/scenario/1st-injection2017-05-02T12:22:38-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/scenario/mild-renal-impairment2018-04-17T11:25:38-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/scenario/2nd-injection-of-invega-trinza2017-05-02T12:22:38-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/scenario/transitioning-a-patient-to-invega-trinza2018-04-16T14:25:06-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/scenario/standard-dosing2017-05-02T12:22:37-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/scenario/dosing-window-for-2nd-initiation-dose2017-05-02T12:22:37-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizoaffective/scenario/single-dose-curve-view2017-05-02T12:22:37-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/scenario/single-dose-curve-view2017-05-02T12:22:37-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizoaffective/scenario/switching-from-long-acting-injectable-antipsychotics2017-05-02T12:22:37-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizoaffective/scenario/switching-from-oral-antipsychotics2017-09-21T10:31:17-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizoaffective/scenario/switching-from-oral-invega-er2018-10-17T13:34:55-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizoaffective/scenario/standard-dosing-in-mild-renal-impairment2022-08-23T09:19:28-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizoaffective/scenario/missed-maintenance-dose-6-months2017-05-02T12:22:36-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizoaffective/scenario/missed-maintenance-dose-6-weeks-6-months2017-05-02T12:22:36-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizoaffective/scenario/missed-maintenance-dose-1-month2019-12-11T14:40:12-05:000.5https://www.educationaldoseillustrator.com/pp1m/schizoaffective/scenario/maintenance-dosing-window2017-05-02T12:22:35-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizoaffective/scenario/maintenance-dose-adjustment2019-11-11T16:50:38-05:000.5https://www.educationaldoseillustrator.com/pp1m/schizoaffective/scenario/maintenance-dosing2017-05-02T12:22:35-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizoaffective/scenario/missed-2nd-initiation-dose-7-weeks-1st-injection2017-05-02T12:22:35-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizoaffective/scenario/missed-2nd-initiation-dose-4-7-weeks-1st-injection2017-05-02T12:22:34-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizoaffective/scenario/missed-2nd-initiation-dose2017-05-02T12:22:34-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizoaffective/scenario/dosing-window-for-2nd-initiation-dose2017-05-02T12:22:34-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizoaffective/scenario/initiation-dosing2017-05-02T12:22:34-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizoaffective/scenario/standard-dosing2017-05-02T12:22:34-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/scenario/switching-from-long-acting-injectable-antipsychotics2017-05-02T12:22:34-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/scenario/switching-from-oral-antipsychotics2017-09-21T10:31:04-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/scenario/switching-from-oral-invega-er2018-10-17T13:33:13-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/scenario/standard-dosing-in-mild-renal-impairment2022-08-23T09:16:21-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/scenario/missed-maintenance-dose-6-months2017-05-02T12:22:33-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/scenario/missed-maintenance-dose-6-weeks-6-months2017-05-02T12:22:32-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/scenario/missed-maintenance-dose-1-month2019-12-11T14:41:06-05:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/scenario/maintenance-dosing-window2017-05-02T12:22:32-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/scenario/maintenance-dose-adjustment2019-12-11T14:28:23-05:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/scenario/maintenance-dosing2018-04-13T10:47:26-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/scenario/missed-2nd-initiation-dose-7-weeks-1st-injection2017-05-02T12:22:32-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/scenario/missed-2nd-initiation-dose-4-7-weeks-1st-injection2017-05-02T12:22:32-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/scenario/missed-2nd-initiation-dose2017-05-02T12:22:32-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/scenario/initiation-dosing2017-05-02T12:22:31-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/faq/overview2017-05-02T12:22:17-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizoaffective/faq/overview2020-10-23T17:00:47-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/faq/overview2017-05-02T12:22:07-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/faq/injection-rotation-of-deltoid-gluteal-muscles2017-05-02T12:22:07-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/faq/injection-rotation-of-deltoid-gluteal-muscles2017-05-02T12:22:17-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/faq/needle-selection-overview2017-05-02T12:22:07-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/faq/needle-selection-deltoid-injection2017-05-02T12:22:08-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/faq/needle-selection-overview2017-05-02T12:22:17-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/faq/needle-selection-gluteal-injection2017-05-02T12:22:08-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizoaffective/faq/injection-rotation-of-deltoid-gluteal-muscles2017-05-02T12:22:00-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/faq/kit-contents-description2017-05-02T12:22:08-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/faq/needle-selection-deltoid-injection2017-05-02T12:22:17-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/faq/injection-partial-dose2017-05-02T12:22:08-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizoaffective/faq/needle-selection-overview2017-05-02T12:22:01-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/faq/injection-route-of-administration2017-05-02T12:22:08-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/faq/needle-selection-gluteal-injection2017-05-02T12:22:17-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/faq/tolerability-testing2017-05-02T12:22:08-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizoaffective/faq/needle-selection-deltoid-injection2017-05-02T12:22:00-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/faq/general-initiation-dosing-rationale2021-05-11T21:55:41-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/faq/kit-contents-description2022-10-13T11:02:51-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizoaffective/faq/needle-selection-gluteal-injection2017-05-02T12:22:01-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/faq/rationale-deltoid-administration-for-initiation-doses2021-05-11T21:59:51-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizoaffective/faq/kit-contents-description2017-05-02T12:22:00-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/faq/rationale-lack-of-initiation-doses-when-switching-from-another-long-acting-injectable-antipsychotic2021-05-11T22:03:17-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/faq/injection-partial-dose2017-05-02T12:22:18-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizoaffective/faq/injection-partial-dose2017-05-02T12:22:00-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/faq/second-dose-administration-flexible-time-frame2021-05-11T22:09:49-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/faq/incomplete-administration2017-05-02T12:22:18-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizoaffective/faq/injection-route-of-administration2017-05-02T12:22:00-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/faq/management-of-missed-second-initiation-dose2017-05-02T12:22:09-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/faq/injection-route-of-administration2017-05-02T12:22:18-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizoaffective/faq/tolerability-testing2017-05-02T12:22:01-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/faq/general-maintenance-dose2017-05-02T12:22:09-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/faq/adjusting-the-maintenance-dose2017-05-02T12:22:09-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/faq/transition-to-invega-trinza2017-05-02T12:22:18-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizoaffective/faq/general-initiation-dosing-rationale2017-05-02T12:21:59-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/faq/dosage-strength-selection-maintenance-dose2017-05-02T12:22:09-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/faq/monthly-dosing-flexible-administration-timeframe2017-05-02T12:22:09-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/faq/dosage-adjustments2017-05-02T12:22:18-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizoaffective/faq/rationale-deltoid-administration-for-initiation-doses2017-05-02T12:22:01-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/faq/management-missed-maintenance-dose2017-05-02T12:22:09-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/faq/renal-impairment2021-12-03T14:01:13-05:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/faq/flexible-dose-administration-window2017-05-02T12:22:18-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizoaffective/faq/rationale-lack-of-initiation-doses-when-switching-from-another-long-acting-injectable-antipsychotic2017-05-02T12:22:01-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/faq/management-of-missed-dose-3½-to-4-months-since-last-injection2017-05-02T12:22:18-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizoaffective/faq/second-dose-administration-flexible-time-frame2017-05-02T12:22:01-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/faq/hepatic-impairment2017-05-02T12:22:10-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/faq/geriatric-use2017-05-02T12:22:10-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/faq/management-of-missed-dose-4-to-9-months-since-last-injection2017-05-02T12:22:18-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizoaffective/faq/management-of-missed-second-initiation-dose2017-05-02T12:22:00-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/faq/coadministration-with-strong-cyp3a4-inducers-p-glycoprotein-p-gp-inducers2017-07-27T16:39:24-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/faq/from-oral-invega-er-to-invega-sustenna-general-overview2018-08-01T13:51:19-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/faq/management-of-missed-dose-9-months-since-last-injection2017-05-02T12:22:19-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizoaffective/faq/general-maintenance-dose2017-05-02T12:22:00-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/faq/from-oral-antipsychotic-to-invega-sustenna-general-overview2017-07-27T16:36:36-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/faq/renal-impairment2017-05-02T12:22:19-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizoaffective/faq/adjusting-the-maintenance-dose2017-05-02T12:21:59-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/faq/long-acting-injectable-antipsychotic-invega-sustenna-initiation2017-05-02T12:22:10-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/faq/hepatic-impairment2017-05-02T12:22:19-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizoaffective/faq/dosage-strength-selection-maintenance-dose2017-05-02T12:21:59-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizoaffective/faq/coadministration-with-strong-cyp3a4-inducers-p-glycoprotein-p-gp-inducers2017-07-27T16:39:16-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/faq/geriatric-use2017-05-02T12:22:19-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizoaffective/faq/monthly-dosing-flexible-administration-timeframe2017-05-02T12:22:00-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizoaffective/faq/long-acting-injectable-antipsychotic-invega-sustenna-initiation2020-10-23T17:06:41-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizoaffective/faq/from-oral-antipsychotic-to-invega-sustenna-general-overview2020-10-23T17:06:29-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/faq/coadministration-with-strong-inducers-of-cyp3a4-and-p-gp-e-g-carbamazepine-rifampin-or-st-johns-wort2017-05-02T12:22:19-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizoaffective/faq/management-missed-maintenance-dose2017-05-02T12:22:00-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/faq/from-long-acting-injectable-antipsychotics2017-05-02T12:22:19-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizoaffective/faq/renal-impairment2021-12-03T13:59:52-05:000.5https://www.educationaldoseillustrator.com/pp1m/schizoaffective/faq/geriatric-use2017-05-02T12:22:00-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizoaffective/faq/hepatic-impairment2017-05-02T12:22:00-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/faq/from-invega-trinza-to-invega-sustenna2017-05-02T12:22:19-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/faq/from-invega-trinza-to-oral-invega-er-tablets2017-05-02T12:22:20-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/faq/transition-from-risperdal-consta2017-05-02T12:22:20-04:000.5https://www.educationaldoseillustrator.com/pp3m/schizophrenia/faq/transition-from-other-lai-antipsychotics-other-than-invega-sustenna-or-risperdal-consta2017-05-02T12:22:20-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizoaffective/faq/from-oral-invega-er-to-invega-sustenna-general-overview2020-10-23T17:12:25-04:000.5https://www.educationaldoseillustrator.com/pp1m/schizophrenia/faq/from-oral-risperdal-to-invega-sustenna-general-overview2018-10-17T10:09:56-04:000.5